Literature DB >> 30914260

d-cycloserine blunts motor cortex facilitation after intermittent theta burst transcranial magnetic stimulation: A double-blind randomized placebo-controlled crossover study.

Ben Selby1, Frank P MacMaster2, Adam Kirton3, Alexander McGirr4.   

Abstract

Entities:  

Keywords:  Cortical plasticity; Cycloserine; Motor cortex; NMDA receptor; Theta-burst TMS

Year:  2019        PMID： 30914260     DOI： 10.1016/j.brs.2019.03.026

Source DB:  PubMed          Journal:  Brain Stimul        ISSN： 1876-4754            Impact factor:   8.955


× No keyword cloud information.
  5 in total

Review 1.  Evidence of Neuroplastic Changes after Transcranial Magnetic, Electric, and Deep Brain Stimulation.

Authors:  Julius Kricheldorff; Katharina Göke; Maximilian Kiebs; Florian H Kasten; Christoph S Herrmann; Karsten Witt; Rene Hurlemann
Journal:  Brain Sci       Date:  2022-07-15

Review 2.  Intrinsic Connectivity Networks of Glutamate-Mediated Antidepressant Response: A Neuroimaging Review.

Authors:  Ilya Demchenko; Vanessa K Tassone; Sidney H Kennedy; Katharine Dunlop; Venkat Bhat
Journal:  Front Psychiatry       Date:  2022-05-26       Impact factor: 5.435

Review 3.  The Problem and Potential of TMS' Infinite Parameter Space: A Targeted Review and Road Map Forward.

Authors:  Kevin A Caulfield; Joshua C Brown
Journal:  Front Psychiatry       Date:  2022-05-10       Impact factor: 5.435

4.  NMDA receptor partial agonist, d-cycloserine, enhances 10 Hz rTMS-induced motor plasticity, suggesting long-term potentiation (LTP) as underlying mechanism.

Authors:  Joshua C Brown; William H DeVries; Jeffrey E Korte; Gregory L Sahlem; Leonardo Bonilha; E Baron Short; Mark S George
Journal:  Brain Stimul       Date:  2020-01-08       Impact factor: 8.955

5.  NMDA-receptor agonist reveals LTP-like properties of 10-Hz rTMS in the human motor cortex.

Authors:  Joshua C Brown; Shiwen Yuan; William H DeVries; Nicole M Armstrong; Jeffrey E Korte; Gregory L Sahlem; Linda L Carpenter; Mark S George
Journal:  Brain Stimul       Date:  2021-03-29       Impact factor: 8.955
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.